Table 3.
Postoperative pathological findings and the FIGO stage distribution in SLN mapping and PLND groups.
| Number (%) | |||
|---|---|---|---|
| SLN† (n = 109) | PLND‡ (n = 94) | p value∗ | |
| Histological grade | |||
| Grade 1 | 91 (83.6%) | 44 (46.8%) | <0.001 |
| Grade 2 | 16 (14.7%) | 37 (39.4%) | |
| Grade 3 | 2 (1.8%) | 13 (13.8%) | |
|
| |||
| Cervical involvement | 10 (9.2%) | 19 (20.2%) | 0.076 |
| Lymphovascular space invasion (LVSI) present | 8 (7.3%) | 12 (12.8%) | 0.196 |
| Peritoneal washings positive | 3 (2.8%) | 9 (9.6%) | 0.08 |
|
| |||
| Final FIGO stage (2009) | SLN (n = 109) | PLND (n = 94) | |
| 1A | 81 (74.3%) | 50 (53.2%) | 0.013 |
| 1B | 14 (12.8%) | 26 (27.7%) | |
| 2 | 5 (4.6%) | 10 (10.6%) | |
| 3A | 4 (3.7%) | 1 (1.1%) | |
| 3C1 | 5 (4.6%) | 6 (6.4%) | |
| 3C2 | 0 (0.0%) | 1 (1.1%) | |
†SLN = sentinel lymph node mapping group. ‡PLND = pelvic lymph node dissection group. ∗Chi-square analysis for p value.